INGN vs CRVL

For growth investors, CorVel Corporation (CRVL) is the stronger pick with 12.

6% revenue growth year-over-year, versus 3. 9% for Inogen, Inc. (INGN). CorVel Corporation (CRVL) offers the better valuation at 31. 7x trailing P/E (33. 4x forward), making it the more compelling value choice. Analysts rate Inogen, Inc. (INGN) a "Buy" — based on 11 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, CorVel Corporation (CRVL) delivered a total return of +45.

7%, compared to -89. 2% for Inogen, Inc. (INGN). Over 10 years, the gap is even starker: CRVL returned +267. 5% versus INGN's -85. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), CorVel Corporation (CRVL) is the lower-risk stock at 0.

48β versus Inogen, Inc. 's 1. 10β — meaning INGN is approximately 131% more volatile than CRVL relative to the S&P 500. On balance sheet safety, CorVel Corporation (CRVL) carries a lower debt/equity ratio of 9% versus 9% for Inogen, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), CorVel Corporation (CRVL) is pulling ahead at 12.

6% versus 3. 9% for Inogen, Inc. (INGN). On earnings-per-share growth, the picture is similar: Inogen, Inc. grew EPS 44. 1% year-over-year, compared to 24. 5% for CorVel Corporation. Over a 3-year CAGR, CRVL leads at 11. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

CorVel Corporation (CRVL) is the more profitable company, earning 10.

6% net margin versus -6. 5% for Inogen, Inc. — meaning it keeps 10. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CRVL leads at 13. 5% versus -8. 7% for INGN. At the gross margin level — before operating expenses — INGN leads at 47. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, CorVel Corporation (CRVL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

48), +267. 5% 10Y return). Both have compounded well over 10 years (CRVL: +267. 5%, INGN: -85. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (INGN (Healthcare) and CRVL (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.